Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.094 AUD | -1.05% | -4.08% | +327.27% |
04-30 | Nyrada's NYR-BI03 Being Studied For Potential in Traumatic Brain Injury | MT |
04-18 | Transcript : Nyrada Inc., Q3 2024 Earnings Call, Apr 18, 2024 |
Sales 2022 | 1.09 1.69 87.58 | Sales 2023 | 1.43 2.21 114.49 | Capitalization | 4.37M 6.75M 350M |
---|---|---|---|---|---|
Net income 2022 | -3M -4.63M -240M | Net income 2023 | -7M -10.81M -560M | EV / Sales 2022 | 9,367,032 x |
Net cash position 2022 | 10.82M 16.71M 866M | Net cash position 2023 | 3.71M 5.73M 297M | EV / Sales 2023 | 461,207 x |
P/E ratio 2022 |
-4.5
x | P/E ratio 2023 |
-0.56
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 30.03% |
Latest transcript on Nyrada Inc.
1 day | -1.05% | ||
1 week | -4.08% | ||
Current month | -5.05% | ||
1 month | -5.05% | ||
3 months | +308.70% | ||
6 months | +347.62% | ||
Current year | +327.27% |
Managers | Title | Age | Since |
---|---|---|---|
James Bonnar
CEO | Chief Executive Officer | - | 31/01/18 |
Founder | - | 28/08/17 | |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 28/08/17 | |
Ruediger Weseloh
BRD | Director/Board Member | - | 31/05/19 |
Marcus Frampton
BRD | Director/Board Member | 44 | 31/05/19 |
Date | Price | Change | Volume |
---|---|---|---|
30/04/24 | 0.094 | -1.05% | 618,536 |
29/04/24 | 0.095 | +1.06% | 558,347 |
26/04/24 | 0.094 | -2.08% | 1,351,825 |
24/04/24 | 0.096 | -2.04% | 321,445 |
23/04/24 | 0.098 | -.--% | 189,588 |
Delayed Quote Australian S.E., April 30, 2024 at 07:10 am
More quotes1st Jan change | Capi. | |
---|---|---|
+327.27% | 11.18M | |
+34.00% | 664B | |
+29.29% | 567B | |
-7.75% | 354B | |
+18.53% | 330B | |
+4.95% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.89% | 148B |
- Stock Market
- Equities
- NYR Stock